humulin 70/30 suspension for injection
lilly france s.a.s. - insulin human (recombinant dna) - suspension for injection - 100iu/ml
humulin n suspension for injection
lilly france s.a.s. - insulin human isophane (recombinant dna) - suspension for injection - 100iu/ml
humulin i kwikpen 100units/ml suspension for injection 3ml pre-filled pens
eli lilly and company ltd - insulin isophane human - suspension for injection - 100unit/1ml
humulin r- insulin human injection, solution humulin r- insulin human injection, solution
eli lilly and company - insulin human (unii: 1y17cti5sr) (insulin human - unii:1y17cti5sr) - insulin human 100 [iu] in 1 ml - humulin r is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. humulin r is contraindicated: - during episodes of hypoglycemia [see warnings and precautions (5.3)] - in patients with hypersensitivity to humulin r or any of its excipients [see warnings and precautions (5.5)] risk summary available data from published studies over decades have not established an association with human insulin use during pregnancy and major birth defects, miscarriage, or adverse maternal or fetal outcomes (see data) . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations). animal reproduction studies were not performed. the estimated background risk of major birth defects is 6-10% in women with pre-gestational diabetes with a hba1c >7% and has been reported to be as high as 20-25% in women with a hba1c >10%. the estimated background risk of miscarriage for the indicated population is unknown. in the u.s. general p
humulin nph kwikpen biosynthetic human isophane insulin 100iu/ml injection multidose syringe
eli lilly australia pty ltd - insulin -
humulin 30/70 kwikpen injection multidose syringe
eli lilly australia pty ltd - insulin -
humulin r solution for injection
eli lilly and company - insulin human regular (recombinant dna) - solution for injection - 100iu/ml
humulin n- insulin human injection, suspension sterile diluent- diluent injection, solution
eli lilly and company - insulin human (unii: 1y17cti5sr) (insulin human - unii:1y17cti5sr) - insulin human 100 [iu] in 1 ml - humulin n is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. humulin n is contraindicated: - during episodes of hypoglycemia [see warnings and precautions (5.3)] , and - in patients who have had hypersensitivity reactions to humulin n or any of its excipients [see warnings and precautions (5.5)] . risk summary available data from published studies over decades have not established an association with human insulin use during pregnancy and major birth defects, miscarriage, or adverse maternal or fetal outcomes (see data). there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations). animal reproduction studies were not performed. the estimated background risk of major birth defects is 6-10% in women with pre-gestational diabetes with a hba1c >7% and has been reported to be as high as 20-25% in women with a hba1c >10%. the estimated background risk of miscarriage for the indicated population is unkn
humulin r- insulin human injection, solution
physicians total care, inc. - insulin human (unii: 1y17cti5sr) (insulin human - unii:1y17cti5sr) - insulin human 100 [iu] in 1 ml - humulin r u-100 is indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 1 and type 2 diabetes mellitus. humulin r u-100 may be administered intravenously under proper medical supervision in a clinical setting for glycemic control (see dosage and administration and storage). humulin r u-100 is contraindicated during episodes of hypoglycemia and in patients hypersensitive to humulin r u-100 or any of its excipients. never share needles and syringes. correct syringe type doses of insulin are measured in units . u-100 insulin contains 100 units/ml (1 ml=1 cc). with humulin r, it is important to use a syringe that is marked for u-100 insulin preparations. failure to use the proper syringe can lead to a mistake in dosage, causing serious problems for you, such as a blood glucose level that is too low or too high. syringe use to help avoid contamination and possible infection, follow these instructions exactly. disposable syringes and needles should be used only
humulin n suspension for injection
eli lilly and company 16ch.des conquelicots p.o box 580 ch-1214 - human insulin - suspension for injection - humulin injections contain biosynthetic human - insulins and analogues for injection